Sermorelin for Sale: Read the Lot Before the Price

Summary: Two sermorelin listings can quote the same purity figure and describe very different things. This page reads a listing field by field, using one published certificate as the worked example.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Sermorelin for sale is a phrase attached to listings that look nearly identical and are not equally informative. Same white powder, same vial photograph, same confident purity number. The difference lives in fields most listings skip, and every one of those fields is readable in about a minute if you know what it is for.

The listing this page works through is below, so the fields can be checked against something live rather than a hypothetical.

Where readers actually buy it

Ascension Peptides — Sermorelin

Research-grade Sermorelin, assayed by an outside lab and shipped from the US. The code below takes half off the vial.

Code at checkoutPEPTIDEDECK50% off
Sermorelin · 10 mg$72.00$36.00$3.60/mgGet the 10 mg →

The published certificate for lot 38-01260229 assays this vial at 11.31 mg against a 10 mg label, and reports purity and quantity only, with no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.

  • Batch certificate published for the lot
  • Free shipping over $250
  • Ships same day if ordered before 2pm CST

What you are looking at before you look at the listing

Sermorelin is a synthetic 29 amino acid peptide equal to the active front end of human growth hormone releasing hormone, written as GHRH(1-29) amide. Its formula is C149H246N44O42S, its molecular weight 3357.9 g/mol, and it sits in PubChem under CID 16132413 [3]. It binds the GHRH receptor on the anterior pituitary and asks that gland to release the growth hormone your body already makes. That makes it a secretagogue rather than a hormone. If you arrived here thinking it is another name for HGH, it is not, and that distinction changes what a listing should be telling you.

It also has a history that most research peptides do not have. Sermorelin was sold in the United States as Geref, an EMD Serono product, under two applications: NDA 019863 for pituitary diagnostics, with submissions from 1991, and NDA 020443 for treatment, approved on 26 September 1997 [1]. Both are now marked Discontinued in FDA's records, and the same record carries the Federal Register determination that the product was not discontinued or withdrawn for safety or effectiveness reasons [1]. Commercial exit, not a recall. There is no current US label, and no marketed product to compare a listing against.

Sermorelin for sale: the fields that separate a real listing from a decorated one

FieldWhat a serious listing publishesWhat a thin one does insteadWhy it decides anything
Compound and formNames sermorelin acetate and states lyophilised powderA product name and a photoForm determines storage, handling and whether reconstitution is even part of the purchase
Labelled quantityA milligram figure on the vialVial size onlyNothing can be priced per milligram until this exists
Lot numberA batch code printed on the certificate and matching the vialA certificate with no lot, or one certificate reused across productsAn unmatched certificate describes somebody else's material
Testing scopeNames each assay individually: purity, identity, and separately anything about endotoxin or sterilityThe phrase third party tested with no documentPurity and identity do not answer the injectable question
LaboratoryA named lab with an address you can look upAn unbranded PDFA self issued document verifies nothing
Analysis dateWhen the assay ran, not when the page was writtenNothingA two year old certificate on a fresh batch is a mismatch
StorageHow the sealed vial should be keptNothingHandling instructions are part of what you paid for
Use statementResearch use only, with no human use claims anywhere on the pageDosing tables, protocols, benefit listsA seller making clinical claims has misunderstood its own position

The pattern in the middle column is rarely a lie. It is omission, which costs the seller nothing and is much harder to complain about afterwards.

The worked example: lot 38-01260229

The listing above publishes one certificate, and it is specific enough to check. MZ Biolabs, of 2102 N Country Club Rd, Tucson, Arizona, analysed lot 38-01260229 on 7 February 2026 and signed the report on 13 February. The method was HPLC-UV-MS. Purity came back at 99.79 percent across four detected peaks, and the analyst of record was Ken Pendarvis.

Two things on that document are worth more than the purity figure.

The first is identity. The sequence printed on the certificate converts to YADAIFTNSYRKVLGQLSARKLLQDIMSR, twenty nine residues with a C terminal amide, which is canonical GHRH(1-29). Cross referenced against PubChem CID 16132413 the formula and mass agree [3]. That is the vial holding the compound the listing names, confirmed rather than asserted.

The second is quantity. The certificate reports 11.31 mg in a vial labelled 10 mg, an overfill of 13.1 percent on that lot. That is a real and checkable number, and it moves the arithmetic: the same money buys more material than the label implies. We work that through in full on our sermorelin price page. Read it as a property of lot 38-01260229 and nothing more. A different lot is a different measurement, and no seller promises a specific fill weight.

What the certificate does not cover, said plainly

This lot's certificate reports purity and quantity. There is no endotoxin test on it and no sterility test on it.

That gap matters more here than it would for a compound nobody reconstitutes. Endotoxin is a fragment of bacterial cell wall. It survives ordinary handling, it is not what a purity assay is looking for, and testing for it is a separate discipline with separate instrumentation. A certificate can be entirely truthful at 99.79 percent and say nothing whatsoever about it.

FDA has stated the concern for this class of compounds in its own words, describing a risk for immunogenicity due to the potential for aggregation and peptide related impurities [2]. That is a testing question before it is anything else, which is exactly why scope is the field to read first.

The claims a sermorelin listing is not allowed to make

Research grade material is sold for laboratory use and not for human consumption, and a listing that respects that boundary reads a particular way. No dosing table. No protocol. No before and after. No claims about sleep, body composition, recovery or ageing.

Those claims would be unsupported even if they were permitted. PubMed returns 332 papers mentioning sermorelin, three with the word in the title, and zero for sermorelin together with anti ageing. ClinicalTrials.gov registers no studies naming it at all, so any listing waving an NCT number at you has attached somebody else's trial. Searching that registry does return results, but they belong to GHRH, tesamorelin and octreotide.

The literature that exists points at the approved indications: paediatric growth hormone deficiency and pituitary function testing. The clinic market sells adult vitality. Those are not the same subject, and a listing that blurs them is telling you something about itself.

Where the price sits in all this

The vial on the card lists at $99.99, sells at $72.00, and comes to $36.00 with the code. Against a 10 mg label that is $3.60/mg, and against the 11.31 mg this particular lot assayed it is $3.18/mg. Quantity tiers of 3, 5 and 10 percent apply to the list price separately from the code, and free shipping starts at $250.

Read those numbers last. A cheaper vial with a fuller certificate beats an expensive one with a partial certificate every time, and the price column will never tell you which you are looking at. If you want the criteria set out as a scoring rule instead of a checklist, that is our sermorelin where to buy page, and the channel comparison including the pharmacy route is on where to buy sermorelin.

We earn a commission if you use the link on the card, which is disclosed on the card itself and in our disclaimer, in line with what the FTC endorsement guides expect of a page like this [4].

Common questions about sermorelin for sale

Is sermorelin legal to buy?
Research grade sermorelin is sold for laboratory use and not for human consumption, which is the basis on which the listing here operates. Separately, sermorelin has a genuine prescription route in the United States, because it was a component of an approved drug product and a compounding pharmacy can work from that. Those are two different transactions with two different rule sets.
Why is there no current FDA label for sermorelin?
Because Geref was discontinued. Both applications, NDA 019863 and NDA 020443, are marked Discontinued in FDA's records, and the same record states the product was not discontinued or withdrawn for safety or effectiveness reasons. DailyMed returns no current labelling for it.
Does 99.79 percent purity mean the vial is safe to inject?
No, and the two questions are not related. Purity describes how much of the material is the intended compound. It says nothing about bacterial endotoxin or sterility, which are separate assays that do not appear on this lot's certificate.
Is sermorelin the same thing as HGH?
No. Growth hormone is the hormone itself. Sermorelin is a fragment of the releasing hormone that sits upstream of it, so it acts on the pituitary rather than replacing the hormone. Different molecule, different mechanism, different purchase.
What should I check the moment a vial arrives?
The lot number on the vial against the lot on the certificate you were shown, the labelled quantity, and the physical state of the powder. If the lot codes do not match, you were shown a document about different material.

The short version

A sermorelin listing is worth reading in this order: compound and form, labelled quantity, lot number, testing scope, then price. The example on this page publishes a certificate from a named laboratory for lot 38-01260229, at 99.79 percent purity and 11.31 mg against a 10 mg label, and that same certificate carries no endotoxin or sterility work. Both halves of that sentence are true and both belong in a decision. The compound behind the listing was approved as Geref in 1997 and discontinued for commercial reasons, which makes it unusual in this market, and none of that history says anything about the vial in front of you. Only the certificate does.

References

  1. FDA, Drugs@FDA, Geref (sermorelin acetate), NDA 020443, EMD Serono, original approval 26 September 1997, marketing status Discontinued
  2. FDA, Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act, category lists
  3. PubChem, Sermorelin, CID 16132413, C149H246N44O42S, 3357.9 g/mol
  4. FTC, The Endorsement Guides: What People Are Asking